A systematic review of population based epidemiological studies in Myasthenia Gravis

被引:441
作者
Carr, Aisling S. [1 ]
Cardwell, Chris R. [2 ]
McCarron, Peter O. [2 ]
McConville, John [1 ,3 ]
机构
[1] Royal Victoria Hosp, Dept Neurol, Belfast BT12 6BA, Antrim, North Ireland
[2] Queens Univ Belfast, Dept Epidemiol & Med Stat, Belfast, Antrim, North Ireland
[3] Ulster Hosp, Dept Neurol, Dundonald, North Ireland
关键词
ACETYLCHOLINE-RECEPTOR; NEUROLOGICAL DISEASES; PREVALENCE; ANTIBODIES; PROVINCE; ONSET; DENMARK;
D O I
10.1186/1471-2377-10-46
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: The aim was to collate all myasthenia gravis (MG) epidemiological studies including AChR MG and MuSK MG specific studies. To synthesize data on incidence rate (IR), prevalence rate (PR) and mortality rate (MR) of the condition and investigate the influence of environmental and technical factors on any trends or variation observed. Methods: Studies were identified using multiple sources and meta-analysis performed to calculate pooled estimates for IR, PR and MR. Results: 55 studies performed between 1950 and 2007 were included, representing 1.7 billion population-years. For All MG estimated pooled IR (eIR): 5.3 per million person-years (C.I.: 4.4, 6.1), range: 1.7 to 21.3; estimated pooled PR: 77.7 per illion persons (C.I.: 64.0, 94.3), range 15 to 179; MR range 0.1 to 0.9 per millions person-years. AChR MG eIR: 7.3 (C.I.: 5.5, 7.8), range: 4.3 to 18.0; MuSK MG IR range: 0.1 to 0.32. However marked variation persisted between populations studied with similar methodology and in similar areas. Conclusions: We report marked variation in observed frequencies of MG. We show evidence of increasing frequency of MG with year of study and improved study quality. This probably reflects improved case ascertainment. But other factors must also influence disease onset resulting in the observed variation in IR across geographically and genetically similar populations.
引用
收藏
页数:9
相关论文
共 63 条
  • [1] Epidemiology of myasthenia gravis in northwestern Sardinia
    Aiello, I
    Pastorino, N
    Sotgiu, S
    Pirastru, MI
    Sau, GF
    Sanna, G
    Rosati, G
    [J]. NEUROEPIDEMIOLOGY, 1997, 16 (04) : 199 - 206
  • [2] ALTER M, 1960, ARCH NEUROL-CHICAGO, V3, P65
  • [3] Myasthenia gravis -: A higher than expected incidence in the elderly
    Aragonès, JM
    Bolíbar, L
    Bonfill, X
    Bufill, E
    Mummany, A
    Alonso, F
    Illa, I
    [J]. NEUROLOGY, 2003, 60 (06) : 1024 - 1026
  • [4] Araki S, 1983, Rinsho Shinkeigaku, V23, P838
  • [5] Bateman KJ, 2007, SAMJ S AFR MED J, V97, P959
  • [6] Mortality and survival in myasthenia gravis: a Danish population based study
    Christensen, PB
    Jensen, TS
    Tsiropoulos, I
    Sorensen, T
    Kjaer, M
    Hojer-Pedersen, E
    Rasmussen, MJK
    Lehfeldt, E
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1998, 64 (01) : 78 - 83
  • [7] INCIDENCE AND PREVALENCE OF MYASTHENIA-GRAVIS IN WESTERN DENMARK - 1975 TO 1989
    CHRISTENSEN, PB
    JENSEN, TS
    TSIROPOULOS, I
    SORENSEN, T
    KJAER, M
    HOJERPEDERSEN, E
    RASMUSSEN, MJK
    LEHFELDT, E
    OLIVARIUS, BD
    [J]. NEUROLOGY, 1993, 43 (09) : 1779 - 1783
  • [8] Cisneros A D, 1996, Rev Neurol, V24, P435
  • [9] COCCO AV, 1997, REV NEUROLOGIA, V25, P2068
  • [10] COMPARATIVE-STUDY ON THE PREVALENCE OF MYASTHENIA-GRAVIS IN THE PROVINCES OF BOLOGNA AND FERRARA, ITALY
    DALESSANDRO, R
    GRANIERI, E
    BENASSI, G
    TOLA, MR
    CASMIRO, M
    MAZZANTI, B
    GAMBERINI, G
    CANIATTI, L
    [J]. ACTA NEUROLOGICA SCANDINAVICA, 1991, 83 (02): : 83 - 88